Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
Titel:
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
Auteur:
Herrera, Alex F Chen, Lu Nieto, Yago Holmberg, Leona Johnston, Patrick Mei, Matthew Popplewell, Leslie Armenian, Saro Cao, Thai Farol, Leonardo Sahebi, Firoozeh Spielberger, Ricardo Chen, Robert Nademanee, Auayporn Puverel, Sandrine Nwangwu, Mary Lee, Peter Song, Joo Skarbnik, Alan Kennedy, Neena Peters, Lacolle Rosen, Steven T Kwak, Larry W Forman, Stephen J Feldman, Tatyana